Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 77 INDUSTRY 63 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 179 Leukemia 162 Lymphoma 116 Lung Neoplasms 107 Carcinoma, Non-Small-Cell Lung 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 97 Central Nervous System Neoplasms 84 Sarcoma 82 Prostatic Neoplasms 81 Ovarian Neoplasms 76 Colorectal Neoplasms 71 Head and Neck Neoplasms 70 Leukemia, Myeloid, Acute 60 Squamous Cell Carcinoma of Head and Neck 54 Rectal Neoplasms 54 Neuroblastoma 52 Colonic Neoplasms 52 Multiple Myeloma 51 Uterine Cervical Neoplasms 47 Brain Neoplasms 46 Lymphoma, Large B-Cell, Diffuse 45 Leukemia, Lymphocytic, Chronic, B-Cell 41 Carcinoma, Ovarian Epithelial 41 Burkitt Lymphoma 41 Astrocytoma 40 Glioblastoma 39 Fallopian Tube Neoplasms 39 Neoplasm Metastasis 38 Congenital Abnormalities 37 Lymphoma, Follicular 36

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × Advanced Cancer × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡